OTC Markets OTCPK - Delayed Quote USD
AIM ImmunoTech Inc. (AIMI)
0.0400
+0.0003
+(0.76%)
At close: April 23 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 5,329,616 | 37 |
Sales | 4,580 | 1 |
Net Shares Purchased (Sold) | 5,325,036 | 38 |
Total Insider Shares Held | 5.05M | -- |
% Net Shares Purchased (Sold) | -1,961.80% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
MITCHELL WILLIAM M Director | Purchase at price 0.03 per share. | Direct | 5,000 | Apr 11, 2025 |
EQUELS THOMAS K Chief Executive Officer | Purchase at price 0.03 per share. | Direct | 50,000 | Apr 11, 2025 |
KELLNER TED D Director | Purchase at price 0.03 per share. | Direct | 50,000 | Apr 11, 2025 |
RODINO PETER W III Chief Operating Officer | Purchase at price 0.09 per share. | Direct | 44 | Apr 4, 2025 |
EQUELS THOMAS K Chief Executive Officer | Purchase at price 0.09 per share. | Direct | 3,891 | Apr 4, 2025 |
CHEMEROW DAVID I Director | Stock Award(Grant) at price 0.12 per share. | Direct | 5,208 | Mar 14, 2025 |
MITCHELL WILLIAM M Director | Stock Award(Grant) at price 0.12 per share. | Direct | 5,208 | Mar 14, 2025 |
BRYAN NANCY K Director | Stock Award(Grant) at price 0.12 per share. | Direct | 5,208 | Mar 14, 2025 |
EQUELS THOMAS K Chief Executive Officer | Purchase at price 0.13 per share. | Direct | 6,730 | Mar 5, 2025 |
EQUELS THOMAS K Chief Executive Officer | Purchase at price 0.12 per share. | Direct | 10,000 | Mar 4, 2025 |
EQUELS THOMAS K Chief Executive Officer | Purchase at price 0.12 per share. | Direct | 5,060 | Mar 4, 2025 |
CHEMEROW DAVID I Director | Stock Award(Grant) at price 0.14 per share. | Direct | 2,604 | Feb 28, 2025 |
MITCHELL WILLIAM M Director | Stock Award(Grant) at price 0.14 per share. | Direct | 5,208 | Feb 28, 2025 |
BRYAN NANCY K Director | Stock Award(Grant) at price 0.14 per share. | Direct | 5,208 | Feb 28, 2025 |
MITCHELL WILLIAM M Director | Stock Award(Grant) at price 0.12 per share. | Direct | 5,208 | Feb 14, 2025 |
MITCHELL WILLIAM M Director | Stock Award(Grant) at price 0.12 per share. | Direct | 5,208 | Feb 14, 2025 |
BRYAN NANCY K Director | Stock Award(Grant) at price 0.12 per share. | Direct | 5,208 | Feb 14, 2025 |
MITCHELL WILLIAM M Director | Stock Award(Grant) at price 0.20 per share. | Direct | 5,208 | Jan 31, 2025 |
MITCHELL WILLIAM M Director | Stock Award(Grant) at price 0.20 per share. | Direct | 5,208 | Jan 31, 2025 |
BRYAN NANCY K Director | Stock Award(Grant) at price 0.20 per share. | Direct | 5,208 | Jan 31, 2025 |
MITCHELL WILLIAM M Director | Stock Award(Grant) at price 0.19 per share. | Direct | 5,208 | Jan 15, 2025 |
BRYAN NANCY K Director | Stock Award(Grant) at price 0.19 per share. | Direct | 5,208 | Jan 15, 2025 |
MITCHELL WILLIAM M Director | Stock Award(Grant) at price 0.20 per share. | Direct | 5,208 | Dec 31, 2024 |
BRYAN NANCY K Director | Stock Award(Grant) at price 0.20 per share. | Direct | 5,208 | Dec 31, 2024 |
APPELROUTH STEWART L. Director | Stock Award(Grant) at price 0.20 per share. | Direct | 1,736 | Dec 31, 2024 |
MITCHELL WILLIAM M Director | Sale at price 0.19 per share. | Direct | 884 | Dec 19, 2024 |
EQUELS THOMAS K Chief Executive Officer | Purchase at price 0.21 per share. | Direct | 4,682 | Dec 18, 2024 |
MITCHELL WILLIAM M Director | Stock Award(Grant) at price 0.21 per share. | Direct | 5,208 | Dec 13, 2024 |
BRYAN NANCY K Director | Stock Award(Grant) at price 0.21 per share. | Direct | 5,208 | Dec 13, 2024 |
APPELROUTH STEWART L. Director | Stock Award(Grant) at price 0.21 per share. | Direct | 5,208 | Dec 13, 2024 |
MITCHELL WILLIAM M Director | Stock Award(Grant) at price 0.23 per share. | Direct | 5,208 | Dec 2, 2024 |
BRYAN NANCY K Director | Stock Award(Grant) at price 0.23 per share. | Direct | 5,208 | Dec 2, 2024 |
APPELROUTH STEWART L. Director | Stock Award(Grant) at price 0.23 per share. | Direct | 5,208 | Dec 2, 2024 |
APPELROUTH STEWART L. Director | Purchase at price 0.21 per share. | Direct | 2,356 | Dec 2, 2024 |
EQUELS THOMAS K Chief Executive Officer | Purchase at price 0.21 per share. | Direct | 4,240 | Nov 21, 2024 |
EQUELS THOMAS K Chief Executive Officer | Purchase at price 0.18 per share. | Direct | 11,000 | Nov 20, 2024 |
EQUELS THOMAS K Chief Executive Officer | Purchase at price 0.20 per share. | Direct | 16,915 | Nov 20, 2024 |
APPELROUTH STEWART L. Director | Purchase at price 0.19 per share. | Direct | 15,817 | Nov 20, 2024 |
EQUELS THOMAS K Chief Executive Officer | Purchase at price 0.30 per share. | Direct | 1,515 | Sep 16, 2024 |
EQUELS THOMAS K Chief Executive Officer | Purchase at price 0.31 per share. | Direct | 6,160 | Sep 13, 2024 |
EQUELS THOMAS K Chief Executive Officer | Stock Award(Grant) at price 0.32 per share. | Direct | 100,000 | Sep 11, 2024 |
RODINO PETER W III Chief Operating Officer | Stock Award(Grant) at price 0.27 per share. | Direct | 50,000 | Aug 12, 2024 |
EQUELS THOMAS K Chief Executive Officer | Stock Award(Grant) at price 0.27 per share. | Direct | 100,000 | Aug 12, 2024 |
RODINO PETER W III Chief Operating Officer | Purchase at price 0.41 per share. | Direct | 12,500 | May 6, 2024 |
EQUELS THOMAS K Chief Executive Officer | Purchase at price 0.41 per share. | Direct | 25,000 | May 6, 2024 |
BRYAN NANCY K Director | Purchase at price 0.39 per share. | Direct | 15,000 | Mar 21, 2024 |
RODINO PETER W III Chief Operating Officer | Purchase at price 0.33 per share. | Direct | 12,500 | Mar 15, 2024 |
EQUELS THOMAS K Chief Executive Officer | Purchase at price 0.33 per share. | Direct | 25,000 | Mar 15, 2024 |
APPELROUTH STEWART L. Director | Purchase at price 0.33 per share. | Direct | 30,000 | Mar 15, 2024 |
EQUELS THOMAS K Chief Executive Officer | Purchase at price 0.44 per share. | Direct | 15,000 | Nov 27, 2023 |
Related Tickers
ARMP Armata Pharmaceuticals, Inc.
1.3200
+1.08%
DNTH Dianthus Therapeutics, Inc.
21.56
-1.42%
TTNP Titan Pharmaceuticals, Inc.
3.6999
+5.71%
ERNA Ernexa Therapeutics Inc.
0.1938
+5.21%
BOLD Boundless Bio, Inc.
1.5800
+8.22%
NTHI NeOnc Technologies Holdings, Inc. Common Stock
5.88
-2.00%
GLSI Greenwich LifeSciences, Inc.
9.85
+2.28%
HTD.MU Corcept Therapeutics Inc
60.20
+5.73%
NXOA.BE Nicox SA
0.2275
+0.66%
BT3.BE Lineage Cell Therapeutics Inc
0.4020
+8.06%